D
Cullinan Therapeutics, Inc. CGEM
$8.74 -$0.33-3.64% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -1.79% -17.47% 3.49% -13.14% -56.06%
Total Depreciation and Amortization -1.30% 1.32% -1.30% 1.32% -1.30%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 15.35% 35.98% -33.86% 43.96% 106.96%
Change in Net Operating Assets -137.19% 161.73% 260.45% 80.56% -278.37%
Cash from Operations -17.83% -7.28% 5.93% 5.11% -110.95%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 130.55% -19.69% 110.74% -1,528.77% -74.83%
Cash from Investing 130.55% -19.69% 110.74% -1,528.77% -74.83%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -20.14% -99.26% 24,415.02% 337.50%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 100.00% 82.70% -- --
Cash from Financing -- 19.40% -99.49% 24,065.53% 337.50%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 66.72% -47.50% -131.71% 268.52% -172.07%